Lucintel Forecasts Her2 Antibody Market To Grow At A Cagr Of 8%-10%

By Author: Lucintel LLC
Total Articles: 4752
Comment this article

According to the recent study the HER2 antibody market is projected to grow at a CAGR of 8%-10% from 2020 to 2025. Growth in this market is primarily driven by increasing prevalence of HER2 positive, rising awareness of personalized medicines, and increasing geriatric population.
Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in HER2 antibody market by type of treatment drugs (trastuzumab, lapatinib, ado-trastuzumab emtansine, pertuzumab, and everolimus), application (hospitals and medical centers), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others) and region (North America, Europe, Asia Pacific, and Rest of the World).
Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/her2-antibody-market.aspx
“Trastuzumab market is expected to remain the largest segment during the forecast period.”
Based on type of treatment drugs, the HER2 antibody market is segmented into trastuzumab, lapatinib, ado-trastuzumab emtansine, pertuzumab, ...
... and everolimus. Lucintel forecasts that the trastuzumab market is expected to remain the largest segment during the forecast period due to increasing prevalence of cancer.
“North America will dominate the HER2 antibody market in near future”
North America is expected to be the highest growth over the forecast period over the forecast period due to developed healthcare infrastructure and increasing awareness of population regarding the treatment of HER2 breast cancer in the region.
Download Brochure of this report by clicking on https://www.lucintel.com/her2-antibody-market.aspx
Major players of HER2 antibody market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Roche, Novartis, Abnova, Pfizer, InvivoGen, Biocon, Bio-Techne, Samsung Bioepis and Celltrion are among the major HER2 antibody providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/her2-antibody-market.aspx or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx

Urology Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx

Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx